Anti-spike antibody titers
2 papers study it3 findings
- Humans2
Upstream
1Frailty
downin humans2
2 studies
Frailty
downin humans2
Frailty decreases anti-spike antibody titers in humans (10-fold higher in individuals with lower frailty status (p = 0.001 and p = 0.005, unadjusted and adjusted for prior COVID-19 infection)).
“anti-spike antibody titers were 10-fold higher in individuals with lower frailty status”
Human trialn = 15
Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
Immunity & ageing : I & AJan 17, 2023
Frailty decreases anti-spike antibody titers in humans (5-fold higher in mild vs severe).
“anti-spike antibody titers were higher in 5-fold higher in individuals with mild frailty compared to severe frailty”
Human trialafter 2 vaccine dosesn = 15
Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA Vaccine
Research squareAug 1, 2022Preprint
Associations
1CD8+ CD28- TEMRA cells
downin humans1
1 study
CD8+ CD28- TEMRA cells
downin humans1
CD8+ CD28- TEMRA cells are associated with anti-spike antibody titers in humans (p = 0.036).
“Overall antibody response was inversely correlated with a phenotype of immune-senescent T cells, CD8 + CD28- TEMRA cells (p = 0.036, adjusted for COVID-19 infection).”
Human trialn = 15
Frailty impacts immune responses to Moderna COVID-19 mRNA vaccine in older adults
Immunity & ageing : I & AJan 17, 2023